Phaseline

Companies › GeneCradle

GeneCradle: clinical trials, targets and expected readouts

3 active drug programs in 7 registered trials: 6 Phase 1, 1 Phase 3; Metabolic and endocrine, Neurology, Other; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
GC101
Self-complementary AAV9 delivering codon-optimized SMN coding sequence
SMN1Phase 3SMA - Spinal Muscular Atrophy; Spinal Muscular Atrophy Type 3; Spinal Muscular Atrophy; SMA IIDec 2026
GC301
AAV9 vector delivering functional human GAA gene
GAAPhase 1Pompe Disease Infantile-Onset; Pompe Disease (Late-onset)Dec 2026
GC304
self-complementary AAV5 carrying codon-optimized LPL gene driven by liver-specific promote
LPLPhase 1Hypertriglyceridemia, FamilialDec 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06421831GC101Phase 1Spinal Muscular Atrophy Type 3NeurologyDec 2026
NCT05824169GC101Phase 1Spinal Muscular AtrophyNeurologyDec 2026
NCT05793307GC301Phase 1Pompe Disease Infantile-OnsetMetabolic and endocrineDec 2026
NCT06391736GC301Phase 1Pompe Disease (Late-onset)Metabolic and endocrineDec 2026
NCT05860569GC304Phase 1Hypertriglyceridemia, FamilialMetabolic and endocrineDec 2026
NCT06971094GC101Phase 3SMA - Spinal Muscular AtrophyOtherDec 2026
NCT05901987GC101Phase 1SMA IINeurologyDec 2028

Targets

SMN1 (1) GAA (1) LPL (1)

Companies with the same targets

Novartis Gemma Biotherapeutics Lanyue Biotech (Hangzhou) Biocad Lantu Biopharma Astellas Amicus Therapeutics Sanofi Spark Therapeutics AskBio

Companies built like this

Spark Therapeutics Neurogene Orchard Therapeutics AskBio Shanghai Vitalgen BioPharma

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.